Glaucoma and Brain Changes: How Brain Structure and Size See What Glaucoma Is Doing
Official title: Magnetic Resonance Imaging of Cerebral Connectivity and Volume in Neurodegeneration and Glaucoma
Run by University Hospital, Bordeaux · NCT07802769 · Data updated 2026-11-12
This study tests whether glaucoma is linked to broader brain changes by comparing brain MRI and eye health over time in people with glaucoma and matched controls.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Locations | 1 site (Bordeaux) |
| Status | Recruiting |
| Started | August 28, 2026 |
| Main results expected | May 2027 |
| Study ends | May 2027 |
| Registry record updated | September 3, 2026 |
| Trial ID | NCT07802769 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults who completed the ENVOL study and are willing to participate in follow-up imaging and ophthalmic assessments in France.
✕Probably not a fit
Patients who did not complete the ENVOL study or are unable to undergo MRI or ophthalmic evaluations may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The EVOLUTION study is a 10-year extension that uses 3T MRI to compare brain structure and connectivity between people with glaucoma and matched healthy controls, building on previous ENVOL data. It looks for changes in cerebral volume and network connectivity (Hub Disruption Index) to understand whether glaucomatous damage extends beyond the optic pathway. Participants undergo ophthalmic exams and a non-invasive brain scan, with repeat imaging and eye assessments to track glaucoma progression. The study is observational in design, focusing on longitudinal imaging and clinical correlations. It intends to clarify whether glaucoma is associated with broader CNS degeneration beyond the visual system.
Why it matters
Potential benefit: If successful, this work could improve understanding of glaucoma as a potential brain-wide condition and inform future monitoring and therapeutic strategies.
How similar studies have gone: Previous work with ENVOL showed microstructural changes in optic pathways; this extension aims to extend those findings with longitudinal brain imaging.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * having been previously included and completed the ENVOL study * Ability and willingness to provide informed consent * Having a valid health insurance in France In glaucoma group : * Glaucomatous optic neuropathy, being able to be graded by the vertical C/D ratio * Open angle on gonioscopy in a dark-room testing according to Shaffer's classification (grade 3 or grade 4) * Visual field impairement (at least one of the following) : * 3 adjacent points with at least 5dB loss * one point with a loss of 10dB * a difference of at least 10 dB for 2 adjacent points on either side of the horizontal meridian of the nasal visual field * Mini Mental State Score of at least 28 In control group : * No personal or family history of glaucoma or ocular hypertension (IOP \> 21 mmHg) * Open angle on gonioscopy in a dark-room testing according to Shaffer's classification (grade 3 or grade 4) * Intraocular pressure of ≤ 21 mmHg * Absence of glaucomatous neuropathy * Normal visual field Exclusion Criteria: * Inability/unwillingness to provide informed consent * Other causes of ocular hypertension (trauma, uveitis) * Non-glaucomatous optic neuropathy (infectious, inflammatory, compressive, ischemic) * Unreliable visual field (\>15% false positives, \>33% false negatives or \>20% loss of fixation) * Severe corneal pathology preventing access to fundus, visual field testing or altering ocular tonometry * Contraindications to MRI testing (pacemakers or neurosensory stimulators, cochlear implants, ferromagnetic foreign bodies, claustrophobia) * Patients under guardianship or other form of legal protection
Where it's running
-
CHU Bordeaux
Bordeaux, France Recruiting
Study contacts
- Study coordinator: Cedrick Schweitzer, MD, PhD
- Email: cedric.schweitzer@chu-bordeaux.fr
- Phone: +335 56 79 55 30
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Balance training for people with glaucoma
A randomized study tests whether a structured eight-week balance program helps adults with glaucoma improve balance, reduce fall risk, and lessen fear of falling.
-
Eye drops Rhopressa vs Timolol to protect nerve cells in glaucoma
In adults with open-angle glaucoma, this study tests whether Rhopressa helps preserve retinal nerve cells better than Timolol while both lower eye pressure.
-
Comparison of FT-1000 non-contact tonometry with Goldmann applanation tonometry in glaucoma patients
This study tests whether the FT-1000 non-contact tonometer gives measurements that agree with the Goldmann applanation tonometer in adults with glaucoma.
-
Removing the ripcord from a glaucoma drainage device after 3 months
This study tests whether removing the ripcord from an implanted glaucoma drainage device changes eye pressure for adults with open-angle glaucoma.
-
Long-Term Results After Ab-interno Trabeculotomy for Glaucoma
This study tests whether ab-interno trabeculotomy with the Trabectome can provide sustained intraocular pressure reduction in glaucoma patients who had the procedure between 2019 and 2021.
-
Cross-modal cerebellar stimulation to improve balance and vision in glaucoma
In older adults with glaucoma, this study tests whether different cerebellar transcranial electrical stimulation methods can improve balance and visual-cognitive function.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.